A
Anne Wojtusciszyn
Researcher at University of Lausanne
Publications - 73
Citations - 1780
Anne Wojtusciszyn is an academic researcher from University of Lausanne. The author has contributed to research in topics: Transplantation & Islet. The author has an hindex of 20, co-authored 59 publications receiving 1401 citations. Previous affiliations of Anne Wojtusciszyn include Geneva College & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
Emanuele Bosi,Pratik Choudhary,Harold W. de Valk,Sandrine Lablanche,Javier Castañeda,Simona de Portu,Julien Da Silva,Roseline Ré,Linda Vorrink-de Groot,John H. Shin,Francine R. Kaufman,Ohad Cohen,Andrea Laurenzi,Amelia Caretto,David Slatterly,Marcia Henderson-Wilson,S. John Weisnagel,Marie Christine Dubé,Valérie Ève Julien,Roberto Trevisan,Giuseppe Lepore,Rosalia Bellante,Irene Hramiak,Tamara Spaic,Marsha Driscoll,Sophie Borot,Annie Clergeot,Lamia Khiat,Peter Hammond,Sutapa Ray,Laura Dinning,Giancarlo Tonolo,Alberto Manconi,Maura Serena Ledda,Wendela de Ranitz,Bianca Silvius,Anne Wojtusciszyn,Anne Farret,Titia Vriesendorp,Folkje Immeker-de Jong,Joke van der Linden,Huguette S. Brink,Marije Alkemade,Pauline Schaepelynck-Belicar,Sébastien Galie,Clémence Tréglia,Pierre-Yves Benhamou,Myriam Haddouche,Roel Hoogma,Lalantha Leelarathna,Angel Shaju,Linda James +51 more
TL;DR: Insulin pump therapy with integrated CGM and a suspend-before-low feature reduced the frequency of sensorhypoglycaemic and severe hypoglycaemia events in hypoglyCAemia-prone adults compared with use of continuous subcutaneous insulin infusion without real-time CGM.
Journal ArticleDOI
Expectations and strategies regarding islet transplantation: metabolic data from the GRAGIL 2 trial.
Lionel Badet,Pierre Y. Benhamou,Anne Wojtusciszyn,Reto M. Baertschiger,Laure Milliat-Guittard,Laurence Kessler,Alfred Penfornis,Charles Thivolet,Eric Renard,Domenico Bosco,Philippe Morel,Emmanuel Morelon,François Bayle,Cyrille Colin,Thierry Berney +14 more
TL;DR: The GRAGIL2 trial was designed as a phase 1-2 study where primary outcome was the rate of insulin independence, and secondary outcome was defined by a composite score based upon basal C-peptide, HbA1c, hypoglycemic events, and exogenous insulin needs as discussed by the authors.
Journal ArticleDOI
Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol.
Christian Toso,Reto M. Baertschiger,Philippe Morel,Domenico Bosco,Mathieu Pierre Jean Armanet,Anne Wojtusciszyn,Lionel Badet,Jacques Philippe,C Becker,Karine Hadaya,Pietro Majno,Leo Buhler,Thierry Berney +12 more
TL;DR: The data indicate that the Edmonton approach can be successfully applied to the IAK setting, and this procedure is associated with significant side effects and only patients with stable function of the kidney graft should be considered.
Journal ArticleDOI
Precision medicine in the era of artificial intelligence: implications in chronic disease management.
Murugan Subramanian,Murugan Subramanian,Anne Wojtusciszyn,Lucie Favre,Sabri Boughorbel,Jingxuan Shan,Jingxuan Shan,Khaled Ben Letaief,Nelly Pitteloud,Lotfi Chouchane,Lotfi Chouchane +10 more
TL;DR: The strengths and limitations of existing and evolving recent, data-driven technologies, such as AI, in preventing, treating and reversing lifestyle-related diseases are discussed.
Journal ArticleDOI
Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies.
Jean Bousquet,Christian Jorgensen,Michel Dauzat,Alfredo Cesario,T. Camuzat,Rodolphe Bourret,Nicolas Best,Josep M. Antó,Frédéric Abecassis,Pierre Aubas,Antoine Avignon,Mélanie Badin,Anna Bedbrook,Hubert Blain,Arnaud Bourdin,Jacques Bringer,William Camu,Guilhaume Cayla,D. J. Costa,Philippe Courtet,Jean-Paul Cristol,Pascal Demoly,Jean Emmanuel de La Coussaye,Pierre Fesler,Fares Gouzi,Jean-Christophe Gris,Bernard Guillot,Maurice Hayot,Claude Jeandel,Olivier Jonquet,Laurent Journot,Sylvain Lehmann,Gwenaelle Mathieu,Jacques Morel,Grégory Ninot,Jacques Pélissier,Marie Christine Picot,Françoise Radier-Pontal,Jean-Marie Robine,Michel Rodier,François Roubille,Ariane Sultan,Anne Wojtusciszyn,Charles Auffray,Rudi Balling,Cristina Bárbara,Anne Cambon-Thomsen,Niels H. Chavannes,A.G. Chuchalin,George Crooks,Antoni Dedeu,Leonardo M. Fabbri,Judith Garcia-Aymerich,Jawad Hajjam,Elisabete Melo Gomes,Susana Palkonen,François Piette,Christophe Pison,David Price,Bolesław Samoliński,Holger J. Schünemann,Peter J. Sterk,Panayiotis K. Yiallouros,Josep Roca,Philippe Van de Perre,Jacques Mercier +65 more
TL;DR: An innovative integrated health system built around systems medicine and strategic partnerships is proposed to combat NCDs and two practical examples of systems medicine applied to allergy and to NCD co-morbidities are proposed.